Hikma Pharmaceuticals PLC H5P.F Stock
Hikma Pharmaceuticals PLC Price Chart
Hikma Pharmaceuticals PLC H5P.F Financial and Trading Overview
| Hikma Pharmaceuticals PLC stock price | 21.4 EUR |
| Previous Close | 22.4 EUR |
| Open | 22.6 EUR |
| Bid | 22.6 EUR x N/A |
| Ask | 22.8 EUR x N/A |
| Day's Range | 22.6 - 22.6 EUR |
| 52 Week Range | 13.5 - 22.6 EUR |
| Volume | 56 EUR |
| Avg. Volume | 2 EUR |
| Market Cap | 4.99B EUR |
| Beta (5Y Monthly) | 0.390038 |
| PE Ratio (TTM) | 28.974361 |
| EPS (TTM) | 0.79 EUR |
| Forward Dividend & Yield | 0.52 (2.33%) |
| Ex-Dividend Date | March 23, 2023 |
| 1y Target Est | N/A |
H5P.F Valuation Measures
| Enterprise Value | 5.89B EUR |
| Trailing P/E | 28.974361 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.9842746 |
| Price/Book (mrq) | 2.331339 |
| Enterprise Value/Revenue | 2.341 |
| Enterprise Value/EBITDA | 7.724 |
Trading Information
Hikma Pharmaceuticals PLC Stock Price History
| Beta (5Y Monthly) | 0.390038 |
| 52-Week Change | 27.58% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 22.6 EUR |
| 52 Week Low | 13.5 EUR |
| 50-Day Moving Average | 20.68 EUR |
| 200-Day Moving Average | 18.04 EUR |
H5P.F Share Statistics
| Avg. Volume (3 month) | 2 EUR |
| Avg. Daily Volume (10-Days) | 5 EUR |
| Shares Outstanding | 220.99M |
| Float | 154.03M |
| Short Ratio | N/A |
| % Held by Insiders | 31.01% |
| % Held by Institutions | 37.65% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.56 |
| Trailing Annual Dividend Yield | 2.50% |
| 5 Year Average Dividend Yield | 185.00% |
| Payout Ratio | 0.6316 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 7.46% |
| Operating Margin (ttm) | 23.48% |
| Gross Margin | 50.25% |
| EBITDA Margin | 30.31% |
Management Effectiveness
| Return on Assets (ttm) | 8.35% |
| Return on Equity (ttm) | 8.27% |
Income Statement
| Revenue (ttm) | 2.52B EUR |
| Revenue Per Share (ttm) | 11.24 EUR |
| Quarterly Revenue Growth (yoy) | -2.50% |
| Gross Profit (ttm) | 1.27B EUR |
| EBITDA | 763M EUR |
| Net Income Avi to Common (ttm) | 188M EUR |
| Diluted EPS (ttm) | 0.78 |
| Quarterly Earnings Growth (yoy) | -91.29% |
Balance Sheet
| Total Cash (mrq) | 292M EUR |
| Total Cash Per Share (mrq) | 1.33 EUR |
| Total Debt (mrq) | 1.28B EUR |
| Total Debt/Equity (mrq) | 59.73 EUR |
| Current Ratio (mrq) | 1.856 |
| Book Value Per Share (mrq) | 9.694 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 530M EUR |
| Levered Free Cash Flow (ttm) | 299.5M EUR |
Profile of Hikma Pharmaceuticals PLC
| Country | Germany |
| State | N/A |
| City | London |
| Address | 1 New Burlington Place |
| ZIP | W1S 2HR |
| Phone | 44 20 7399 2760 |
| Website | https://www.hikma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 8800 |
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company was founded in 1978 and is headquartered in London, the United Kingdom.
Q&A For Hikma Pharmaceuticals PLC Stock
What is a current H5P.F stock price?
Hikma Pharmaceuticals PLC H5P.F stock price today per share is 21.4 EUR.
How to purchase Hikma Pharmaceuticals PLC stock?
You can buy H5P.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hikma Pharmaceuticals PLC?
The stock symbol or ticker of Hikma Pharmaceuticals PLC is H5P.F.
Which industry does the Hikma Pharmaceuticals PLC company belong to?
The Hikma Pharmaceuticals PLC industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hikma Pharmaceuticals PLC have in circulation?
The max supply of Hikma Pharmaceuticals PLC shares is 221.88M.
What is Hikma Pharmaceuticals PLC Price to Earnings Ratio (PE Ratio)?
Hikma Pharmaceuticals PLC PE Ratio is 27.08860600 now.
What was Hikma Pharmaceuticals PLC earnings per share over the trailing 12 months (TTM)?
Hikma Pharmaceuticals PLC EPS is 0.79 EUR over the trailing 12 months.
Which sector does the Hikma Pharmaceuticals PLC company belong to?
The Hikma Pharmaceuticals PLC sector is Healthcare.